A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, researchers found in a clinical trial. File Photo by Brian Kersey/UPI A powerful new ...

Prostate cancer deaths in the United States were on the decline, thanks to advances in screening and treatment but new data from the American Cancer Society (ACS) shows that the tide is shifting — ...

The rate of young people dying from cancer is dropping across the United States, but death rates from one type of cancer have ...

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care, new data show.

The PLCO model may improve prediction of prostate cancer death at the point of screening. The Stockholm3 test may improve screening itself. A new prostate cancer-specific mortality (PCSM) model may ...

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society. In the US, advanced prostate cancer diagnoses ...

Many men with low levels could be spared from invasive procedures and frequent testing ...

An Italian oncologic psychologist warns these patients: “A prostatectomy doesn’t cure anxiety.” Emotional distress can be so ...